The table below summarizes the most recent Vicarious Surgical insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Vicarious Surgical insider buys are important for investors to follow.

Date	Insider	Price	Amount
8-7-2023 Insider Buy	Khosla Ventures V, L.P. >10% Owner	$1.00 CAGR »	$8,000,000.00 8,000,000 shares
5-10-2023 Insider Buy	Philip Liang Director	$1.99 CAGR »	$13,958.00 7,000 shares
4-11-2023 Insider Buy	Philip Liang Director	$2.26 CAGR »	$38,407.52 17,002 shares
4-10-2023 Insider Buy	Philip Liang Director	$2.20 CAGR »	$13,035.00 5,925 shares
4-6-2023 Insider Buy	Philip Liang Director	$2.05 CAGR »	$6,150.00 3,000 shares
3-28-2023 Insider Buy	Philip Liang Director	$2.32 CAGR »	$172,227.40 74,300 shares
3-27-2023 Insider Buy	Philip Liang Director	$2.07 CAGR »	$152,973.00 73,900 shares
3-24-2023 Insider Buy	Philip Liang Director	$1.65 CAGR »	$99,146.12 60,125 shares
3-23-2023 Insider Buy	Philip Liang Director	$1.71 CAGR »	$125,538.00 73,500 shares
3-13-2023 Insider Buy	Philip Liang Director	$2.36 CAGR »	$139,366.35 59,100 shares
3-9-2023 Insider Buy	Philip Liang Director	$2.50 CAGR »	$92,623.86 37,100 shares
2-23-2023 Insider Buy	Philip Liang Director	$2.86 CAGR »	$107,141.25 37,500 shares
2-22-2023 Insider Buy	Philip Liang Director	$2.83 CAGR »	$35,432.50 12,500 shares
2-14-2023 Insider Buy	Philip Liang Director	$3.02 CAGR »	$3,618.72 1,200 shares
2-8-2023 Insider Buy	Philip Liang Director	$3.05 CAGR »	$240,740.42 79,009 shares
2-6-2023 Insider Buy	Philip Liang Director	$3.05 CAGR »	$81,773.55 26,811 shares
2-6-2023 Insider Buy	Philip Liang Director	$3.05 CAGR »	$81,773.55 26,811 shares
9-17-2021 Insider Buy	Endeavors LP Innovation III >10% Owner	$10.00 CAGR »	$3,333,330.00 333,333 shares
9-17-2021 Insider Buy	Khosla Ventures V, L.P. >10% Owner	$10.00 CAGR »	$3,333,340.00 333,334 shares

Also See: Institutional Holders of RBOT
Also See: SEC filings

Below we present the annualized performance delivered by Vicarious Surgical stock since 8-7-2023 (the date of the most recent insider purchase). The performance of the investment from the time Vicarious Surgical insider buying occurred is the ultimate test of whether insiders were right about RBOT being a good buy.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	08/08/2023
End date:	04/24/2024
Start price/share:	$0.88
End price/share:	$0.27
Dividends collected/share:	$0.00
Total return:	-68.91%
Annualized Gain:	-96.73%
Starting investment:	$10,000.00
Ending investment:	$3,109.00
Years:	0.71

Vicarious Surgical Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Vicarious Surgical insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding RBOT

RBOT — Current Quote

Quotes delayed 20 minutes

Free RBOT Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

RBOT — Performance

More Insider Buying

Other companies seeing insider buying close in time to when the Vicarious Surgical Insider Buying occurred are:

Alset Capital Acquisition Insider Buying
Sandy Spring Bancorp Insider Buying
Skillz Insider Buying
CarParts.com Inc (New) Insider Buying
CKX Lands Insider Buying
BJs Restaurants Insider Buying
VistaGen Therapeutics Insider Buying
Rogers Insider Buying
Industrial Logistics Properties Trust Insider Buying
Travelzoo Insider Buying

Vicarious Surgical Insider Buying

Vicarious Surgical Insider Buying | www.HoldingsChannel.com